Experimental substantiation of effectively administration of vinboron for analgesic activity increase of ibuprofen

Authors

  • F. V. Hladkykh National Pirogov Memorial Medical University,
  • N. H. Stepaniuk National Pirogov Memorial Medical University,

DOI:

https://doi.org/10.14739/2409-2932.2016.3.77934

Keywords:

Ibuprofen, Vinboron, PASS Analysis, Antinociceptive Effect

Abstract

Background. The increase of NSAIDs safety is current direction of modern pharmacology, because of so-called "class-specific" adverse reactions, which are common to this class, and the leading place among them is occupied by gastro-intestinal toxicity. In previous studies we have proved the ability of vinboron to neutralize ulcerogenic effect of ibuprofen (Hladkykh F.V. and al., 2014). The presence of the proven analgesic activity in the domestic antispasmodics (Stepaniuk H.I. and al., 2007) serves as the basis for research of vinboron action on analgesic aspect of ibuprofen pharmacotherapeutic effec.

Aim is to conduct research in silico of the relation «molecular structure – anelgetic activity» of vinboron and to prove experimentally in vivo the practicability of vinboron using with the aim to increase the analgesic activity of ibuprofen on the model of adjuvant arthritis in rats.

Materials and methods. The study of the relation «molecular structure – activity anelgetic» of vinboron was conducted in silico by PASS- analysis of biological activity spectrum. The analysis was set online with direct insertion of structural formula of vinboron in browser using Marvin JS web-resource «PASS Online» (http://www.way2drug.com/passonline). Analgesic activity in vivo was studied on the model of acute thermal pain, which was simulated in the conventional behavioral test of nociception «Hot plate». The lag of pain reaction was determined at the beginning («0» day), on 7, 14, 21 and 28 days of experiment.

Results and discussion. According to the PASS-forecast the mechanisms of vinboron analgesic activity is caused by agonism towards the vanilloid (TRPV1) receptors (Pa=0,490; Pi=0,008), agonism to the μ (mu) – receptor (Pa=0,323; Pi=0,036), inhibition of GABA (Pa=0,329; Pi=0,089) and others. Experimental studies have shown that the combined administration of ibuprofen and vinboron analgesic activity was higher than the results by ibuprofen monotherapy at a dose of 73 mg/kg up by 15.3%, and at a dose of 218 mg/kg up by 20.4%. Besides, it is worthwhile to note that analgesic activity during the integrated administration of ibuprofen at a dose of 218 mg/kg and vinboron (+39.8%) was higher than the total analgesic activity of ibuprofen monotherapy at the same dose (+19.4%) and monotherapy of vinboron (+10.9%), that points at  potentiation of analgesic effect of both drugs during their integrated administration.

Conclusions. According to the PASS-analysis, the leading mechanism in analgesic component implementation of vinboron is its agonism to TRPV1. The results of our in vivo studies point at the ability of vinboron to intensify the antinociceptive activity of ibuprofen.

References

Herndon, C. M., Hutchison, R. W., Berdine, H. J., Stacy, Z. A., Chen, J. T., Farnsworth, D. D., et al. (2008). Management of chronic nonmalignant pain with non-steroidal anti-inflammatory drugs. Pharmacotherapy, 28(6), 788–805. doi: 10.1592/phco.28.6.788.

Zupanec, I. A. (2013). Simtomaticheskaya pomoshch pri boli: vzglyad na problemu [Symptomatic assistance with pain, look at the problem]. Farmacevt praktik, 3, 24–25. [in Ukrainian].

Smith, S. R., Deshpande B. R., Collins J. E., Katz J. N., & Losina E. (2016). Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage, 24(6), 962–972. doi: 10.1016/j.joca.2016.01.135.

Costa, B. R., Reichenbach, S., Keller, N., Nartey, L., Wandel, S., Juni, P., & Trelle, S. (2016). Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet, 21(387), 2093–2105. doi: 10.1016/s0140-6736(16)30002-2.

Nefedov, O. O., & Mamchur, V. I. (2009). Farmakolohichni aspekty vplyvu nesteroidnykh protyzapalnykh zasobiv ta klasychnykh spazmolitykiv na vistseralnyi bil v eksperymenti [Pharmacological aspects of the impact of NSAIDs and classic antispasmodics for visceral pain experiment]. Farmakolohiia ta likarska toksykolohiia, 1(8), 15–19. [in Ukrainian].

Chornoivan, N. H., Chornobrovyi, V. N., Stepaniuk H. I., Shalamai, A. S., & Stepaniuk, A. H. (2010). Vinboron – novyi vitchyznianyi spazmolityk z hastroprotektornoiu diieiu [Vinboron – the new a domestic antispasmodic with the gastroprotective action]. Suchasna hastroenterolohiia, 3(53), 54–57. [in Ukrainian].

Popov, O. S., Shebeko, S. K., Shevchenko, O. I., & Shalamaiy, A. S. (2015). Eksperymentalne doslidzhennia protyzapalnykh vlastyvostei preparatu «Dyklokor» [Experimental study of anti-inflammatory properties of the drug "Dyklokor"]. Klinichna farmatsiia, 19(4), 35–39. [in Ukrainian].

Podpletnyaya, E. A., Mazur, I. A., & Mamchur, V. I. (2008). Rol´ kvercetina i tiotriazolina v povyshenii e´ffektivnosti NPVS pri asepticheskom vospalenii i visceral´noj boli u myshej [Role of quercetin and thiotriazoline in enhancing the effectiveness of NSAIDs in aseptic inflammation and visceral pain in mice]. Zaporozhskij medicinskij zhurnal, 2(1), 129–134. [in Ukrainian].

Kashuba, O. V. (2015). Pobichni reaktsii, sprychyneni zastosuvanniam nesteroidnykh protyzapalnykh preparativ – analhetykiv-antypiretykiv [Side effects caused by the use of nonsteroidal anti-inflammatory drugs – analgesic-antipyretics]. Ukrainskyi medychnyi chasopys, 2(107), 74–76. [in Ukrainian].

Stepaniuk, N. H., Hladkykh, F. V., & Basarab, O. V. (2015). Analiz pobichnykh reaktsii na tli zastosuvannia analhetykiv-antypiretykiv ta nesteroidnykh protyzapalnykh zasobiv, yaki pryznachalys likariamy zakladiv okhorony zdorovia Podilskoho rehionu u 2015 rotsi. Galician Medical Journal, 2(23), 92–98. [in Ukrainian].

Hladkykh, F. V., & Stepaniuk, N. H. (2015) Kharakterystyka protyzapalnoi ta zneboliuiuchoi aktyvnosti ibuprofenu ta yoho kombinatsii z vinboronom na modeli ad’iuvantnoho artrytu u shchuriv [Characteristics of the inflammatory and analgesic activity of ibuprofen and its combination with the model vinboronom adjuvant arthritis in rats]. Visnyk naukovykh doslidzhen, 2(79), 108–111. [in Ukrainian].

Lagunin, A. A., Filimonov, D. А., & Poroikov, V. V. (2010). Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr. Pharm. Des, 16(15), 1703–1717.

Goel, R. K., Singh, D., Lagunin, A. A., & Poroikov, V. V. (2011). PASS-assisted exploration of new therapeutic potential of natural products. Med. Chem. Res., 20(9), 1509–1514. doi:10.1007/s00044-010-9398-y.

Stephanov, O. V. (Ed) (2001). Doklinichni doslidzhennia likarskykh zasobiv [Preclinical studies of drugs]. Kyiv: Avicena. [in Ukrainian].

Ulashchik, V. S., Kuklova, E. N., & Morozova, I. L. (2012). Dejstvie nizkochastotnogo ul´trazvuka na nociceptivnuyu chuvstvitel´nost´ u krys [The action of low-frequency ultrasound on nociceptive sensitivity in rats]. Fizioterapiya, bal'neologiya i reabilitaciya, 5, 3–8. [in Russian].

Yadlovskyi, O. Ye. (2012) Rol vaniloidnoho komponenta v antynotsytseptyvnii dii dyklofenaku [The role of vanilloid component antinociceptive action of diclofenac]. Farmakolohiia ta likarska toksykolohiia, 1, 60–64. [in Ukrainian].

Rainsford, K. D. (2012). Ibuprofen: pharmacology, therapeutics and side effects. Heidelberg: Springer Basel.

Rybolovlev, Yu. R., & Rybolovlev, R. S. (1979). Dozirovanie veshchestv dlya mlekopitayushchikh po konstantam biologicheskoj aktivnosti [Dosing mammals substances constants of biological activity]. Doklady Akademii nauk SSSR, 6, 1513–1516. [in Russian].

Eddy, N. B., & Leinback, D. (1953) Synthetic analgesics. II. Dithienyl-butenyl and dithienylbutylamines. Journal of Pharmacology and Experimental Therapeutics, 107, 385–393.

Shih, W. J., & Aisner, J. (2016). Statistical design and analysis of clinical trials: principles and methods. Boca Raton: CRC Press.

Mironov, N. Yu., & Churyukanov, V. V. (2006). Vaniloidnye receptory: struktura, uchastie v regulirovanii funkcii organizma, farmakologiya, terapevtichekij potencial [Vanilloid receptors: structure, regulatory functions, pharmacology, therapeutic potential]. E´ksperimental'naya i klinicheskaya farmakologiya, 69(5), 55–69. [in Russian].

Entire, D. M., Kirkpatrick, D. R., Dueck, N. P., Kerfeld, M. J., Smith, T. A., Nelson, T. J., et al. (2016). Pain transduction: a pharmacologic perspective. Expert Rev. Clin. Pharmacol, 23, 1–12. doi: 10.1080/17512433.2016.1183481.

Downloads

How to Cite

1.
Hladkykh FV, Stepaniuk NH. Experimental substantiation of effectively administration of vinboron for analgesic activity increase of ibuprofen. Current issues in pharmacy and medicine: science and practice [Internet]. 2016Sep.22 [cited 2024Apr.25];9(3). Available from: http://pharmed.zsmu.edu.ua/article/view/77934

Issue

No. 3 (2016)

Section

Experimental and clinical pharmacology

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)